SCF and APC E3 Ubiquitin Ligases in Tumorigenesis
(Sprache: Englisch)
This SpringerBrief explores the physiological roles of Skp1-Cullin1-F-box Complex (SCF) and Anaphase Promoting Complex (APC) in normal cells and in tumor formation. These two related, multi-subunit E3 ubiquitin ligase enzymes, APC and SCF are thought to be...
Leider schon ausverkauft
versandkostenfrei
Buch
53.49 €
26 DeutschlandCard Punkte
sammeln
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
- Ratenzahlung möglich
Produktdetails
Produktinformationen zu „SCF and APC E3 Ubiquitin Ligases in Tumorigenesis “
Klappentext zu „SCF and APC E3 Ubiquitin Ligases in Tumorigenesis “
This SpringerBrief explores the physiological roles of Skp1-Cullin1-F-box Complex (SCF) and Anaphase Promoting Complex (APC) in normal cells and in tumor formation. These two related, multi-subunit E3 ubiquitin ligase enzymes, APC and SCF are thought to be the major driving forces governing proper cell cycle progression. Defective cell cycle regulation leads to genomic instability and ultimately, cancer development. Selective degradation of key cell cycle regulators by the ubiquitin-proteasome system has been proven to be a major regulatory mechanism for ensuring ordered and coordinated cell cycle progression. The SCF and APC E3 ligases have been characterized to play pivotal roles in regulating the cell cycle progression by timely degrading various critical cell cycle regulators. This Brief reviews recent studies that have shown that deregulation of signaling pathways in which the two ubiquitin ligases are involved causes aberrant cell cycle regulation, in turn leading to tumorigenesis. The text also discusses how SCF and APC may present promising therapeutic targets to treat various cancers.
Inhaltsverzeichnis zu „SCF and APC E3 Ubiquitin Ligases in Tumorigenesis “
1) Introduction. .-2) The Fbxw subclass of SCF E3 ubiquitin Ligases. .-3) The FbxL subclass of SCF E3 ubiquitin Ligases. .-4) The Fbxo subclass of SCF E3 ubiquitin Ligases. .-5) APC/Cdc20 and APC/Cdh1 E3 ubiquitin Ligases. .-6) Conclusions and Future Perspectives.
Autoren-Porträt von Hiroyuki Inuzuka, Wenyi Wei
Wenyi Wei, Ph.D, is Associate Professor of Pathology at Beth Israel Deaconess Medical Center, Harvard Medical School. Dr. Wei is an expert in the mE3 ubiquitin ligase complexes. He's on the editorial board of several journals including American Journal of Cancer Research, Molecular and Cellular Biology, Cancer Hallmarks, Cancer Research, and Journal of Biological Chemistry. He has published 47 scientific papers, which have received over 2,740 citations. Hiroyuki Inuzuka, Ph.D is Assistant Professor of Pathology at Beth Israel Deaconess Medical Center, Harvard Medical School.
Bibliographische Angaben
- Autoren: Hiroyuki Inuzuka , Wenyi Wei
- 2014, 124 Seiten, Maße: 15,5 x 23,5 cm, Kartoniert (TB), Englisch
- Verlag: Springer
- ISBN-10: 3319050257
- ISBN-13: 9783319050256
- Erscheinungsdatum: 08.04.2014
Sprache:
Englisch
Kommentar zu "SCF and APC E3 Ubiquitin Ligases in Tumorigenesis"
0 Gebrauchte Artikel zu „SCF and APC E3 Ubiquitin Ligases in Tumorigenesis“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "SCF and APC E3 Ubiquitin Ligases in Tumorigenesis".
Kommentar verfassen